Outcomes and Prognostic Factors of Transurethral Bipolar Plasmakinetic Resection of the Bladder Tumor in Renal Transplant Recipients

刘余庆,卢剑,肖春雷,侯小飞,黄毅,马潞林

DOI: https://doi.org/10.3969/j.issn.1009-6604.2016.04.009

2016-01-01

Abstract:Objective To investigate the efficiency and safety of transurethral bipolar plasmakinetic resection of the bladder tumor ( PK-TURBT) in renal transplant recipients , and to evaluate the risk factors of postoperative recurrence of tumor . Methods This retrospective study included 16 cases of clinically diagnosed superficial bladder tumors after renal transplantation .They were treated by PK-TURBT and followed by intravasical instillation from September 2009 to June 2014.In procedures , we vapo-resected and removed bladder tumors , reaching the deep muscle layer of the bladder .Risk factors of tumor recurrence were evaluated with Cox ’ s proportional hazards regression model analysis . Results The procedures of PK-TURBT were performed successfully with a mean operation time of 34.1 min (range, 15 -60 min).Of the cases, 8 cases (8/16, 50.0%) developed recurrence during a median follow-up period of 45 months (range, 14-62 months).Among them, 7 cases (7/8,87.5%) developed recurrence within 2 years after PK-TURBT.By multivariate analyses , native aristolochic acid nephropathy ( HR=7.040, 95% CI: 1.411 -35.121, P =0.017) and tumor size ≥3 cm (HR=8.230, 95%CI:1.055-59.834, P=0.046) were identified as independent predictors for the development of recurrence after PK-TURBT for bladder cancer in renal transplant recipients . Conclusions Transurethral bipolar plasmakinetic resection of the bladder tumor is effective for superficial bladder carcinoma after renal transplantation , with low risk of complications .The incidence of postoperative recurrence is high , and most subsequent cancers recur within 2 years after surgery .The recurrence risk is higher in cases with native aristolochic acid nephropathy and tumor size ≥3 cm.